This Week in MMWR - Vol. 71, August 12, 2022

["Morbidity and Mortality Weekly Report \(MMWR\) \(CDC\)" <no-reply@xxxxxxxxxxxxxxxxxxxx>]

Reports on COVID-19 Testing, Overdoses Involving Bath Salts, and more

August 12, 2022

WEEKLY REPORT

COVID-19 Self-Test Data: Challenges and Opportunities — United States, October 31, 2021–June 11, 2022 During October 31, 2021–June 11, 2022, 10.7 million test results were voluntarily reported by users of four manufacturers’ self-tests; during that period, 361.9 million laboratory-based and point-of-care test results were reported. Completeness of reporting demographic variables and trends in percent positivity were similar across test types.

• Vital Signs: Hepatitis C Treatment Among Insured Adults — United States, 2019–2020
• Epidemiologic and Clinical Characteristics of Monkeypox Cases — United States, May 17–July 22, 2022
• Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection — United States, August 2022
• Notes from the Field: School-Based and Laboratory-Based Reporting of Positive COVID-19 Test Results Among School-Aged Children — New York, September 11, 2021–April 29, 2022
• Notes From the Field: Overdose Deaths Involving Eutylone (Psychoactive Bath Salts) — United States, 2020

READ MORE

QUICKSTATS

 

Percentage of Adults Aged ≥18 Years with Current Hepatitis C Virus Infection, by Health Insurance Coverage — National Health and Nutrition Examination Survey, United States, January 2017–March 2020

PDF of this Issue (link).

CONTINUING EDUCATION

READ MORE

MMWR Weekly COVID-19 Briefing Podcast: Week of July 25

The latest MMWR Weekly COVID-19 Briefing is live. This episode covers six reports, including reports highlighting gun carrying among youth, the safety of a second COVID-19 booster dose among adults aged 50 years and older and more. Listen and subscribe on: Apple Podcasts, Stitcher, Spotify, and Google Play.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |